BillionToOne: BillionToOne detects genetic disorders in the developing baby from maternal blood. We are a Y Combinator (S17) company.
Social Links
What is BillionToOne's Revenue?
BillionToOne's estimated revenue for 2023 is $2M.
What does BillionToOne do?
BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible for all. Our patent-pending molecular counter platform is the only technology platform that can accurately count the DNA molecules to the single-count level.
You May Also Find These Company Reviews Interesting